Pfizer breakup speculation eclipses dismal earnings
This article was originally published in Scrip
Executive Summary
If Pfizer is going to break itself into multiple drug companies, the move appears to be at least more than three years away. That doesn’t diminish the intense interest the company created by announcing a business reorganization this week.